Related Experiment Video

Updated: Aug 19, 2026

A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity
15:04

A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity

Published on: May 5, 2009

Lead toxicity as related to glutathione metabolism

J M Hsu

    The Journal of Nutrition
    |January 1, 1981
    PubMed

    Insights

    Lead exposure in rat pups significantly reduced body weight and altered blood parameters. However, lead poisoning increased glutathione levels in key organs, suggesting a protective response.

    Area of Science:

    • Biochemistry
    • Toxicology
    • Developmental Biology

    Background:

    • Lead poisoning is a significant environmental health concern, particularly for developing organisms.
    • Glutathione plays a critical role in cellular defense against oxidative stress and detoxification.

    Purpose of the Study:

    • To investigate the impact of lead acetate exposure on glutathione metabolism in developing rats.
    • To understand the compensatory mechanisms involved in mitigating lead toxicity.

    Main Methods:

    • Rat pups were exposed to lead acetate through their dams' diet.
    • Measurements included body weight, hematocrit, hemoglobin, organ weights, plasma amino acid levels, and glutathione concentrations.
    • Isotope tracing (cystine-35S and glycine-1-14C) was used to assess glutathione and protein synthesis.

    Main Results:

    • Lead exposure significantly reduced body weight gain and hematological parameters.
    • Organ weights (liver, kidney, spleen, brain) increased in lead-exposed pups.
    • Glutathione concentrations increased in erythrocytes, liver, and kidney; isotope studies showed increased cystine and glycine incorporation into glutathione.
    • Glutathione reductase and peroxidase activities remained unaffected.

    Conclusions:

    • Lead poisoning induces significant physiological changes in developing rats.
    • Elevated glutathione levels appear to be a compensatory mechanism to counteract lead-induced oxidative stress and toxicity.
    • The findings highlight the complex metabolic adaptations to heavy metal exposure.

    More Related Videos

    Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases14:57

    Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

    Published on: October 10, 2020

    Rapid Quantification of Oxidized and Reduced Forms of Glutathione Using Ortho -phthalaldehyde in Cultured Mammalian Cells In Vitro03:35

    Rapid Quantification of Oxidized and Reduced Forms of Glutathione Using Ortho -phthalaldehyde in Cultured Mammalian Cells In Vitro

    Published on: June 28, 2024

    Related Concept Videos

    Types of Toxins01:36

    Types of Toxins

    Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
    Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
    Environmental pollutants like...
    Toxic Reactions: Overview01:26

    Toxic Reactions: Overview

    When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
    Toxicity falls into two primary categories: local and systemic.
    Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
    In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
    Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

    Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

    Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
    Several distinctive characteristics distinguish glutathione conjugation from other phase II...
    Drug Toxicity: Dose-Dependent Reactions01:24

    Drug Toxicity: Dose-Dependent Reactions

    Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
    Sulfur Assimilation01:20

    Sulfur Assimilation

    Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
    Hepatic Encephalopathy01:29

    Hepatic Encephalopathy

    DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...